RxDoctor Payments Data

David Donohue, MD

Orthopaedic Trauma · Temple Terrace, FLNPI 1639436363

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $42,805 of the $64,461 with a category attached, or 66.4%. Smith+Nephew accounts for 88.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $33,399 and has fallen 99.0% since, to $319 in 2025.

$64,461in general payments, 2019–2025

Across 144 payments — averaging $447.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$57K
  • Depuy Synthes Products, Inc.$3K
  • Stryker$2K
  • Medical Device Business Services, Inc.$2K
  • Innovation Technologies Inc$582
  • Johnson & Johnson$301
  • plus $733 from 14 others

What the payments were for

  • Consulting fees$8,02012%
  • Speaking & faculty fees$42,80566%
  • Travel & lodging$8,17013%
  • Food & beverage$5,4668%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,461 in reported general payments places this provider in the 75th percentile of 65 orthopaedic trauma providers in Florida.

See all orthopaedic trauma providers in Florida

Medicare billing

Part B allowed, 2024
$523,825
Medicare patients
647
Services billed
9,978

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib101$1,199
Diclofenac Sodium35$1,080
Methylprednisolone156$1,029
Meloxicam160$494
Ondansetron Hcl43$355
Cephalexin49$337
Oxycodone Hcl51$191
Tramadol Hcl59$161
Gabapentin35$139
Amoxicillin110$126
Clindamycin Hcl23$49

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Temple Terrace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →